Latest Gilead Sciences Stories
Phase 1b Clinical Studies Ongoing in Patients with Chronic HBV Infection DOYLESTOWN, Pa., Nov.
DALLAS, October 29, 2014 /PRNewswire/ -- ReportsnReports.com adds Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline
FLINT, Mich., Oct. 22, 2014 /PRNewswire/ -- U.S.
VANCOUVER, BC and PLYMOUTH, MI, Oct.
Editor Note: For more information about this release, please scroll to bottom. NEW YORK, October 20, 2014 /PRNewswire/ -- Today, Analysts Review released its research
BURLINGAME, Calif., Oct.
Provides use, cost forecast based on testing, future treatment rates ST. PAUL, Minn., Oct. 10, 2014 /PRNewswire/ -- Today's U.S.
BEERSE, Belgium, September 29, 2014 /PRNewswire/ -- CHMP also issues two label extensions for darunavir Janssen-Cilag International NV (Janssen)
- An armed gangster.